JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142369

Sivelestat sodium tetrahydrate, Neutrophil elastase inhibitor

Be the first to review this product! Submit a review

|

(3 Publications)

MW 528.5 Da, Purity >98%. Neutrophil elastase inhibitor. Anti-inflammatory agent. Active in vivo and in vitro.

View Alternative Names

AIS, ANDR_HUMAN, AR, AR8, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), DHTR, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), HUMARA, HYSP1, KD, Kennedy disease (KD), NR3C4, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), SBMA, SMAX1, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), TFM, Testicular Feminization (TFM), androgen receptor splice variant 4b

1 Images
Chemical Structure - Sivelestat sodium tetrahydrate, Neutrophil elastase inhibitor (AB142369)
  • Chemical Structure

Lab

Chemical Structure - Sivelestat sodium tetrahydrate, Neutrophil elastase inhibitor (AB142369)

2D chemical structure image of ab142369, Sivelestat sodium tetrahydrate, Neutrophil elastase inhibitor

Key facts

CAS number

201677-61-4

Purity

>98%

Form

Solid

form

Molecular weight

528.5 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>2</sub><sub>9</sub>N<sub>2</sub>NaO<sub>1</sub><sub>1</sub>S

PubChem

23663985

Nature

Synthetic

Biochemical name

Sivelestat sodium hydrate

Biological description

Neutrophil elastase inhibitor. Anti-inflammatory agent. Active in vivo and in vitro.

Canonical smiles

CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+]

InChi

InChI=1S/C20H22N2O7S.Na.4H2O/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24;;;;;/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24);;4*1H2/q;+1;;;;/p-1

InChiKey

PLHREJBSQUSUCW-UHFFFAOYSA-M

IUPAC Name

sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate;tetrahydrate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The androgen receptor (AR) also known as NR3C4 functions mechanically as a type of nuclear receptor that is activated by binding androgens including testosterone and dihydrotestosterone. The AR has a molecular weight of approximately 110 kDa. It is expressed in various tissues notably in the prostate skeletal muscle and certain areas of the brain. Within cells AR is usually located in the cytoplasm when unbound and translocates to the nucleus upon activation by its ligands.
Biological function summary

AR interacts with androgen hormones to regulate gene expression. It forms a complex with coactivators and corepressors to modulate transcription of target genes involved in male sexual development and reproductive function. AR plays an important role in the development and maintenance of male characteristics and reproductive activity. Its expression impacts cellular processes such as proliferation differentiation and apoptosis.

Pathways

AR is intricately involved in the androgen signaling pathway which affects the regulation of genes related to male sexual characteristics. It also plays a part in the PI3K/Akt pathway influencing cell growth and survival. The AR pathway interacts with proteins such as estrogen receptors to mediate cross-talk between hormonal pathways highlighting its broad biological impacts.

AR has a significant connection to prostate cancer where it drives tumor growth and progression. Mutations and overexpression of the androgen receptor are often observed in prostate cancer cells. Another condition linked to AR is androgen insensitivity syndrome where mutations in the AR gene result in partial or complete inability of cells to respond to androgenic hormones. In these conditions AR antagonists like bicalutamide are often used as treatment inhibiting the receptor's activity to manage disease progression.

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 13:1017 PubMed35197446

2022

Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Xia,Zizhen Zhang,Chunchao Zhu,Bo Ni,Shuchang Wang,Shuofei Yang,Fengrong Yu,Enhao Zhao,Qing Li,Gang Zhao

Frontiers in cellular and infection microbiology 11:677902 PubMed34336711

2021

Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Zhang,Yilu Zhou,Mengdi Qu,Ying Yu,Zhaoyuan Chen,Shuainan Zhu,Kefang Guo,Wankun Chen,Changhong Miao

Diabetologia 62:2365-2374 PubMed31612267

2019

Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.

Applications

Unspecified application

Species

Unspecified reactive species

Haitao Liu,Emma M Lessieur,Aicha Saadane,Sarah I Lindstrom,Patricia R Taylor,Timothy S Kern
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com